Back to Journals » Cancer Management and Research » Volume 13

Corrigendum

Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum]

       
Total article views   HTML views PDF downloads Totals
2,507 Dovepress* 2,427+ 324 2,751
PubMed Central* 80 41 121
Totals 2,507 365 2,872
*Since 16 March 2021

View citations on PubMed Central and Google Scholar